AtaiBeckley (ATAI) FCF Margin (2021 - 2026)
AtaiBeckley's (ATAI) quarterly FCF Margin came in at 2210.69% in Q1 2026, down 104613.0% year-on-year from N/an in Q1 2025, and down 89.83% quarter-over-quarter from 1164.57% in Q1 2025.
AtaiBeckley (ATAI) FCF Margin (2021 - 2026) Analysis & Trends
AtaiBeckley (ATAI) has 5 years of FCF Margin data on file, last reported at 3158.48% in Q3 2025.
- For the quarter ending Q3 2025, FCF Margin rose 4520902.0% year-over-year to 3158.48%; the trailing twelve-month figure through Sep 2025 stood at 2645.21% (up 2158138.0% YoY), and the FY2024 full-year result was 26767.21%, up 12738.0% from the prior year.
- FCF Margin slipped to 2210.69% in Q1 2026 per ATAI's latest filing, from 1164.57% in the prior quarter.
- Across five years, FCF Margin topped out at 1164.57% in Q1 2025 and bottomed at 2210.69% in Q1 2026.
- A 5-year average of 44342.07% and a median of 13069.88% in 2022 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin slumped 10816967 bps in 2022 and soared 9766092 bps in 2023, its largest moves.
- Tracing ATAI's FCF Margin over 5 years: stood at 8873.48% in 2021, then plunged by 809 bps to 80650.0% in 2022, then slumped by 52 bps to 122455.56% in 2023, then slumped by 65 bps to 202458.33% in 2024, then jumped by 98 bps to 3158.48% in 2025.
- Business Quant data shows ATAI's FCF Margin at 3158.48% in Q3 2025, 1977.89% in Q2 2025, and 1164.57% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - | -3,158.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,210.69% |
| Sep 30, 2025 | -3,158.48% |
| Jun 30, 2025 | -1,977.89% |
| Mar 31, 2025 | -1,164.57% |
| Mar 31, 2025 | -1,164.57% |
| Dec 31, 2024 | -202,458.33% |
| Sep 30, 2024 | -48,367.50% |
| Jun 30, 2024 | -5,944.32% |
| Dec 31, 2023 | -122,455.56% |
| Sep 30, 2023 | -21,105.75% |
| Jun 30, 2023 | -13,170.93% |
| Mar 31, 2023 | -57,813.51% |
| Dec 31, 2022 | -80,650.00% |
| Sep 30, 2022 | -118,766.67% |
| Jun 30, 2022 | -12,968.82% |
| Dec 31, 2021 | -8,873.48% |
| Sep 30, 2021 | -10,596.99% |
| Mar 31, 2021 | -0.38% |